Alveron Pharma: Funding, Investors & Team (Sep 2026)
Alveron Pharma develops treatment for hemorrhagic stroke, a severe unmet medical need. Alveron’s drug OKL-1111 strongly reduces hematoma expansion in a mouse model of intracranial hemorrhage. As an injection solution that is ready to use, OKL-1111 is being developed to do away with a laborious pre-treatment process.
Alveron Pharma has raised $5.3M across 1 funding round on record, the most recent a Seed of $5.3M announced in Dec 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Alveron Pharma Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Alveron Pharma Funding Rounds
Alveron Pharma Founders and Leadership Team
Contact details for the Alveron Pharma team: 1 of 1 has an email address on file.
Start 14-day free trial →Alveron Pharma Funding Compared to Other Biotechnology Startups
Alveron Pharma's latest round of $5.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Alveron Pharma in Biotechnology and Nijmegen
Companies Similar to Alveron Pharma
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…
Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…
Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…
Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…
Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…
We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…
QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.
Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…
QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…
BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…
Alveron Pharma Funding FAQs
What does Alveron Pharma do?
Alveron Pharma develops treatment for hemorrhagic stroke, a severe unmet medical need. Alveron’s drug OKL-1111 strongly reduces hematoma expansion in a mouse model of intracranial hemorrhage. As an injection solution that is ready to use, OKL-1111 is being developed to do away with a laborious pre-treatment process.
How much funding has Alveron Pharma raised?
Alveron Pharma has raised $5.3M across 1 round on record. The most recent is a Seed of $5.3M announced in Dec 2024.
When did Alveron Pharma last raise funding?
Alveron Pharma's most recent funding round on record is a Seed of $5.3M, announced in Dec 2024.
Who founded Alveron Pharma?
FundedIQ lists Stephan Peters (Founder) at Alveron Pharma.
Where is Alveron Pharma headquartered?
Alveron Pharma is based in Nijmegen, Gelderland, Netherlands.
How many employees does Alveron Pharma have?
Alveron Pharma is in the 1-10 employee band.
How does Alveron Pharma's funding compare to other Biotechnology startups?
Alveron Pharma's latest round of $5.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Alveron Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alveron Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.